GLP-1 receptor agonist or SGLT2 inhibitor prescribing became more common for people with type 1 diabetes in recent years, a nationwide cross-sectional analysis found. From 2010 to 2023, the percentage ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...
A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for the Study of Diabetes (EASD) meetings. This is an EASD/American Diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results